Finished
ABO-Incompatible Kidney Transplants Between Robot-Assisted vs. Open Surgery
NCT06287008 · Asan Medical Center · Updated 1 March 2024
- What is being tested
- robot-assisted kidney transplantation
- For
- Kidney Transplantation
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 239 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 1 Oct 2020, ends 31 Jan 2024. Registered 29 Feb 2024.
- Results
- None posted yet.
In the researchers' words
While robot-assisted kidney transplantation (RAKT) offers potential benefits such as minimal postoperative pain, better cosmesis, fewer wound infections, and shorter hospital stay, its efficacy in ABO-incompatible (ABO-i) KT compared to open KT (OKT) remains understudied. This study aims to compare ABO-i KT outcomes between RAKT and OKT. The study utilized data from 29 ABO-i RAKT and 210 ABO-i OKT cases performed at Asan Medical Center from October 2020 to February 2023. Univariate and multivariate analyses were performed to evaluate factors associated with a composite of biopsy-proven acute rejection (BPAR), de novo donor-specific antibodies (DSA), and overall graft failure.
Sites
- Asan Medical CenterSeoul, South Korea